Nishiyama O, et al. Body mass index predicts survival in patients with pulmonary hypertension in chronic lung disease. PA1430. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Pembrolizumab bij patiënten met NSCLC en performance status 2
mei 2020 | Immuuntherapie, Longoncologie